scispace - formally typeset
A

Anders Ekbom

Researcher at Karolinska Institutet

Publications -  628
Citations -  56268

Anders Ekbom is an academic researcher from Karolinska Institutet. The author has contributed to research in topics: Population & Risk factor. The author has an hindex of 116, co-authored 613 publications receiving 51430 citations. Previous affiliations of Anders Ekbom include Örebro University & Harvard University.

Papers
More filters
Journal ArticleDOI

External review and validation of the Swedish national inpatient register

TL;DR: The validity of the Swedish IPR is high for many but not all diagnoses, but for certain research areas the use of other health registers, such as the Swedish Cancer Register, may be more suitable.
Journal ArticleDOI

The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research

TL;DR: The Swedish personal identity number (PIN) is described and it is suggested that matching of registers through PIN and matching of national health registers without the explicit approval of theindividual patient is to the benefit for both the individual patient and for society.
Journal ArticleDOI

Ulcerative colitis and colorectal cancer. A population-based study.

TL;DR: Close surveillance and perhaps even prophylactic proctocolectomy should be recommended for patients given a diagnosis of pancolitis, especially those who are less than 15 years of age at diagnosis.
Journal ArticleDOI

Excess Mortality in Bipolar and Unipolar Disorder in Sweden

TL;DR: This population-based study of patients treated in the hospital documented increased SMRs for suicide in patients with bipolar and unipolar disorder and the SMR for all natural causes of death was increased, causing about half the excess deaths.
Journal ArticleDOI

Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis

TL;DR: Risk of lymphoma is substantially increased in a subset of patients with RA, those with very severe disease, and high inflammatory activity, rather than its treatment, is a major risk determinant.